γ-Secretase, notch, Aβ and alzheimer's disease: Where do the presenilins fit in?

Nature Reviews Neuroscience

Volumn 3, Issue 4, 2002, Pages 281-290

  Sisodia, Sangram S ^a   St George Hyslop, Peter H ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; ASPARTIC PROTEINASE; BACE1 PROTEIN, HUMAN; MEMBRANE PROTEIN; NOTCH RECEPTOR; PROTEINASE; SECRETASE; TRANSACTIVATOR PROTEIN;

ALZHEIMER DISEASE; ANIMAL; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ASPARTIC ENDOPEPTIDASES; ENDOPEPTIDASES; HUMANS; MEMBRANE PROTEINS; RECEPTORS, NOTCH; TRANS-ACTIVATORS;

EID: 0036548070     PISSN: 1471003X     EISSN: 14710048     Source Type: Journal    
DOI: 10.1038/nrn785     Document Type: Article

References (137)

1. Price, D. L. & Sisodia, S. S. Mutant genes in familial Alzheimer's disease and transgenic models. Annu. Rev. Neurosci. 21, 479-505 (1998).
2. Schenk, D. et al. Immunization with Aβ attenuates Alzheimer's disease-like pathology in the PDAPP mouse. Nature 400, 173-177 (1999).
3. Bard, F. et al. Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nature Med. 6, 916-919 (2000).
4. Janus, C. et al. Aβ-immunization reduces behavioural impairment and dense-cored plaques in a model of Alzheimer's disease. Nature 408, 979-982 (2000).
5. Morgan, D. et al. Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 408, 982-985 (2000).
6. Fraser, P. E., Darabie, A. A. & McLaurin, J. A. Amyloid-P interactions with chondroitin sulfate-derived monosaccharides and disaccharides. Implications for drug development. J. Biol. Chem. 276, 6412-6419 (2001).
7. Soto, C. et al. β-Sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy. Nature Med. 4, 822-826 (1998).
8. Kisilevsky, R. et al. Arresting amyloidosis in vivo using small- molecule anionic sulphonates or sulphates: implications for Alzheimer's disease. Nature Med. 1, 143-148 (1995).
9. Brown, M. S., Ye, J., Rawson, R. B. & Goldstein, J. L. Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans. Cell 100, 391-398 (2000).
10. Kang, J. et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733-736 (1987).
11. Goldgaber, D. et al. Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science 235, 877-880 (1987).
12. Robakis, N. K. et al. in Disorders of the Developing Nervous System: Changing Views on their Origins, Diagnoses and Treatment (ed. Swann, J. W.) 183-193 (Alan R. Liss, New York, 1988).
13. Tanzi, R. E. et al. Amyloid β-protein gene: cDNA, mRNA distribution and genetic linkage near the Alzheimer locus. Science 235, 880-884 (1987).
14. Kitaguchi, N., Takahashi, Y, Tokushima, Y, Shiojiri, S. & Ito, H. Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity. Nature 331, 530-532
15. Weidemann, A. et al. Identification, biogenesis, and localization of precursors of Alzheimer disease A4 amyloid protein. Cell 57, 115-126 (1989).
16. Haass, C., Koo, E. H., Mellon, A., Hung, A. Y & Selkoe, D. J. Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments. Nature 357, 500-503 (1992).
17. Sisodia, S. S. Secretion of the β -amyloid precursor protein. Ann. NY Acad. Sci. 674, 53-57 (1992).
18. Hung, A. Y & Selkoe, D. J. Selective ectodomain phosphorylation and regulated cleavage of β-amyloid precursor protein. EMBO J. 13, 534-542 (1994).
19. Walter, J. et al. Ectodomain phosphorylation of β-amyloid precursor protein at two distinct cellular locations. J. Biol. Chem. 272, 1896-1903 (1997).
20. Zheng, H. et al. Mice deficient for the amyloid precursor protein gene. Ann. NY Acad. Sci. 777, 421-426 (1996).
21. Saitoh, T. et al. Secreted form of amyloid β-protein is involved in the growth regulation of fibroblasts. Cell 58, 615-622 (1989).
22. Milward, A. E. et al. The amyloid protein precursor of Alzheimer disease is a mediator of the effects of NGF on neurite outgrowth. Neuron 9, 129-137 (1992).
23. Nishimoto, I. et al. Alzheimer amyloid protein precursor complexes with brain GTP-binding protein Go. Nature 362, 75-79 (1993).
24. Kamal, A., Almenar-Queralt, A., LeBlanc, J. F, Roberts, E. A. & Goldstein, L. S. Kinesin-mediated axonal transport of a membrane compartment containing P-secretase and presenilin-1 requires APP. Nature 414, 643-648 (2001).
25. Cao, X. & Sudhof, T. C. A transcriptionally active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293, 115-120 (2001).
26. Sastre, M. et al. Presenilin-dependent γ-secretase processing of β-amyloid precursor protein at a site corresponding to the S3 cleavage of Notch. EMBO Rep. 2, 835-841 (2001).
27. Cupers, P., Orlans, I., Craessaerts, K., Annaert, W. & De Strooper, B. The amyloid precursor protein (APP)- cytoplasmic fragment generated by γ-secretase is rapidly degraded but distributes partially in a nuclear fraction of neurones in culture. J. Neurochem. 78, 1168-1178 (2001).
28. Palmert, M. R. et al. The β-amyloid protein precursor of Alzheimer disease has soluble derivatives found in human brain and cerebrospinal fluid. Proc. Natl Acad. Sci. USA 86, 6338-6342 (1989).
29. Esch, F S. et al. Cleavage of amyloid β-peptide during constitutive processing of its precursor. Science 248, 1122-1124 (1990).
30. Sisodia, S. S., Koo, E. H., Beyreuther, K., Unterbeck, A. & Price, D. Evidence that β-amyloid protein in Alzheimer's disease is not derived by normal processing. Science 248, 492-495 (1990).
31. Wang, R., Meschia, J. F, Cotter, R. J. & Sisodia, S. S. Secretion of the β/A4 amyloid precursor protein. Identification of a cleavage site in cultured mammalian cells. J. Biol. Chem. 266, 16960-16964 (1991).
32. Sahasrabudhe, S. R. et al. Enzymatic generation of the amino terminus of the β-amyloid peptide. J. Biol. Chem. 268, 16699-16705 (1993).
33. Buxbaum, J. D. et al. Evidence that tumor necrosis factor-α converting enzyme is involved in regulated α-secretase cleavage of the Alzheimer amyloid protein precursor. J. Biol. Chem. 273, 27765-27767 (1998).
34. Nitsch, R. M., Slack, B. E., Wurtman, R. J. & Growden, J. H. Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 258, 304-307 (1992).
35. Xu, H., Greengard, P & Gandy, S. Regulated formation of Golgi secretory vesicles containing Alzheimer β-amyloid precursor protein. J. Biol. Chem. 270, 23243-23245 (1995).
36. Parvathy, S., Karran, E. H., Turner, A. J. & Hooper, N. M. The secretases that cleave angiotensin converting enzyme and the amyloid precursor protein are distinct from tumour necrosis factor-a convertase. FEBS Lett. 431, 63-65 (1998).
37. Lammich, S. et al. Constitutive and regulated α-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc. Natl Acad. Sci. USA 96, 3922-3927 (1999).
38. Vassar, R. et al. β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735-741 (1999).
39. Hussain, I. et al. Identification of a novel aspartic protease (Asp2) as β-secretase. Mol. Cell. Neurosci. 14, 419-427 (1999).
40. Sinha, S. et al. Purification and cloning of amyloid precursor protein P-secretase from human brain. Nature 402, 537-540 (1999).
41. Yan, R. et al. Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity. Nature 402, 533-537 (1999).
42. Shoji, M. et al. Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science 258, 126-129 (1992).
43. Haass, C. et al. Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 359, 322-325 (1992).
44. Jarrett, J. T. & Lansbury, P. T. Seeding one-dimensional crystallization of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73, 1055-1058 (1993).
45. Yankner, B. A., Duffy, L. K. & Kirschner, D. A. Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science 250, 279-282 (1990).
46. Pike, C. J., Burdick, D., Walencewicz, A. J., Glabe, C. G. & Cotman, C. W. Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13, 1676-1678 (1993).
47. Lorenzo, A. & Yanker, B. A. β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl Acad. Sci. USA 91, 12243-12247 (1994).
48. Koo, E. H. & Squazzo, S. L. Evidence that production and release of amyloid β-protein precursor involves the endocytic pathway. J. Biol. Chem. 269, 17386-17389 (1994).
49. Koo, E. H., Squazzo, S. L., Selkoe, D. J. & Koo, C. H. Trafficking of cell-surface amyloid β-protein precursor. I. Secretion, endocytosis and recycling as detected by labeled monoclonal antibody. J. Cell Sci. 109, 991-998 (1996).
50. 1-42 peptide is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells. Nature Med. 3, 1021-1023 (1997).
51. 40/42 amyloid peptides. Nature Med. 3, 1016-1020 (1997).
52. Citron, M. et al. Evidence that the 42- and 40-amino-acid forms of amyloid β protein are generated from the β-amyloid precursor protein by different protease activities. Proc. Natl Acad. Sci. USA 93, 13170-13175 (1996).
53. Yasojima, K., Akiyama, H., McGeer, E. G. & McGeer, P. L. Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of β-amyloid peptide. Neurosci. Lett. 297, 97-100 (2001).
54. Qiu, W. Q. et al. Insulin-degrading enzyme regulates extracellular levels of amyloid β-protein by degradation. J. Biol. Chem. 273, 32730-32738 (1998).
55. Chesneau, V., Vekrellis, K., Rosner, M. R. & Selkoe, D. J. Purified recombinant insulin-degrading enzyme degrades amyloid β-protein but does not promote its oligomerization. Biochem. J. 351, 509-516 (2000).
56. Goate, A. M. et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer disease. Nature 349, 704-706 (1991).
57. Sherrington, R. et al. Cloning of a gene bearing missense mutations in early onset familial Alzheimer's disease. Nature 375, 754-760 (1995).
58. Levy-Lahad, E. et al. A familial Alzheimer's disease locus on chromosome 1. Science 269, 970-973 (1995).
59. Rogaev, E. I. et al. Familial Alzheimer's disease in kindreds with missense mutations in a novel gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376, 775-778 (1995).
60. Citron, M. et al. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature 360, 672-674 (1992).
61. Haass, C., Hung, A. Y., Selkoe, D. J. & Teplow, D. B. Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid β-protein precursor. J. Biol. Chem. 269, 17741-17748 (1994).
62. Scheuner, D. et al. Secreted amyloid- β protein similar to that in the senile plaques of Alzheimer disease is increased in vivo by presenilin 1 and 2 and APP mutations linked to FAD. Nature Med. 2, 864-870 (1996).
63. Borchelt, D. R. et al. Familial Alzheimer's disease linked presenilin 1 variants elevate Aβ1-42/1-40 ratio in vitro and in vivo. Neuron 17, 1005-1013 (1996).
64. Duff, K. et al. Increased amyloid- β42(43) in brains of mice expressing mutant presenilin 1. Nature 383, 710-713.(1996).
65. Citron, M. et al. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice. Nature Med. 3, 67-72 (1997).
66. L'Hernault, S. W. L. & Arduengo, P. M. Mutation of a putative sperm membrane protein in Caenorhabditis elegans prevents sperm differentiation but not its associated meiotic divisions. J. Cell Biol. 119, 55-69 (1992).
67. Levitan, D. & Greenwald, I. Facilitation of lin-12--mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. Nature 377, 351-354 (1995).
68. Li, X. & Greenwald, I. HOP-1, a Caenorhabditis elegans presenilin, appears to be functionally redundant with SEL-12 presenilin and to facilitate LIN-12 and GLP-1 signalling. Proc. Natl Acad. Sci. USA 94, 12204-12209 (1998).
69. Doan, A. et al. Protein topology of presenilin. Neuron 17, 1023-1030 (1996).
70. Li, X. & Greenwald, I. Membrane topology of the C. elegans SEL-12 presenilin. Neuron 17, 1015-1021 (1996).
71. De Strooper, B. et al. Phosphorylation, subcellular localization, and membrane orientation of the Alzheimer's disease-associated presenilins. J. Biol. Chem. 272, 3590-3598 (1997).
72. Thinakaran, G. et al. Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 17, 181-190 (1996).
73. Lee, M. K. et al. Hyperaccumulation of FAD-linked presenilin-1 variants in vivo. Nature Med. 3, 756-760 (1997).
74. Thinakaran, G. et al. Evidence that levels of presenilins (PS1 and PS2) are coordinately regulated by competition for limiting cellular factors. J. Biol. Chem. 272, 28415-28422.(1997).
75. Yu, G. et al. The presenilin 1 protein is a component of a high molecular weight intracellular complex that contains β-catenin. J. Biol. Chem. 273, 16470-16475 (1998).
76. Thinakaran, G. et al. Stable association of the presenilin derivatives and absence of presenilin interactions with APP. Neurobiol. Dis. 4, 438-453 (1998).
77. Capell, A. et al. The proteolytic fragments of the Alzheimer's disease associated presenilin-1 form heterodimers and occur as a 100-150 kDa molecular mass complex. J. Biol. Chem. 273, 3205-3211 (1998).
78. Li, Y -M. et al. Presenilin 1 is linked with γ-secretase activity in the detergent solubilized state. Proc. Natl Acad. Sci. USA 97, 6138-6143 (2000).
79. Walter, J. et al. The Alzheimer's disease associated presenilins are differentially phosphorylated proteins located predominantly within the endoplasmic reticulum. Mol. Med. 2, 673-691 (1996).
80. Annaert, W. G. et al. Presenilin 1 controls γ-secretase processing of amyloid precursor protein in pre-Golgi compartments of hippocampal neurons. J. Cell Biol. 147, 277-294 (1999).
81. Cupers, P. et al. The discrepancy between presenilin subcellular localization and y-secretase processing of amyloid precursor protein. J. Cell Biol. 154, 731-740 (2001).
82. Ray, W. J. et al. Cell surface presenilin 1 participates in the γ-secretase-like proteolysis of Notch. J. Biol. Chem. 274, 36801-36807 (1999).
83. Baki, L. et al. Presenilin-1 binds cytoplasmic epithelial cadherin, inhibits cadherin/p120 association, and regulates stability and function of the cadherin/catenin adhesion complex. Proc. Natl Acad. Sci. USA 98, 2381-2386 (2001).
84. Georgakopoulos, A. et al. Presenilin-1 forms complexes with the cadherin/catenin cell-cell adhesion system and is recruited to intercellular and synaptic contacts. Mol. Cell 4, 893-902 (1999).
85. Chung, H.-M. & Struhl, G. Nicastrin is required for Presenilin- mediated transmembrane cleavage in Drosophila. Nature Cell Biol. 3, 1129-1132 (2001).
86. Zhou, J. et al. Presenilin 1 interacts with a novel member of the armadillo family. Neuroreport 8, 2085-2090 (1997).
87. Levesque, G. et al. Presenilins interact with armadillo proteins including neural specific plakophilin related protein and β-catenin. J. Neurochem. 72, 999-1008 (1999).
88. Yu, G. et al. Nicastrin modulates presenilin-mediated notch/glp-1 and βAPP processing. Nature 407, 48-54 (2000).
89. Saura, C. A. et al. The nonconserved hydrophilic loop domain of presenilin (PS) is not required for PS endoproteolysis or enhanced Aβ42 production mediated by familial early onset Alzheimer's disease-linked PS variants. J. Biol. Chem. 275, 17136-17142 (2000).
90. Ho, C. et al. δ-Catenin is a nervous system-specific adherens junction protein which undergoes dynamic relocalization during development. J. Comp. Neurol. 420, 261-276 (2000).
91. Lu, Q. et al. δ-Catenin, an adhesive junction-associated protein which promotes cell scattering. J. Cell Biol. 144, 519-532 (1999).
92. Goutte, C., Hepler, W., Mickey, K. M. & Priess, J. R. aph-2 encodes a novel extracellular protein required for GLP-1- mediated signaling. Development 127, 2481-2492 (2000).
93. Levitan, D., Yu, G., St George-Hyslop, P. & Goutte, C. APH-2/Nicastrin functions in LIN-12/Notch signalling in the C. elegans somatic gonad. Dev. Biol. 240, 654-661 (2001).
94. Lopez-Schier, H. & St Johnston, D. S. Drosophila Nicastrin is essential for the intramembranous cleavage of Notch. Dev. Cell 2, 79-89 (2002).
95. Hu, Y., Ye, Y. & Fortini, M. E. Nicastrin is required for γ-secretase cleavage of the Drosophila Notch receptor. Dev. Cell 2, 69-78 (2002).
96. Chen, F. et al. Nicastrin binds to membrane-tethered Notch. Nature Cell Biol. 3, 751-754 (2001).
97. De Strooper, B. et al. Deficiency of presenilin 1 inhibits the normal cleavage of amyloid precursor protein. Nature 391, 387-390 (1998).
98. Naruse, S. et al. Effect of PS1 deficiency on membrane protein trafficking in neurons. Neuron 21, 1213-1221 (1998).
99. Chen, F. et al. Proteolytic derivative of amyloid precursor protein accumulate in restricted and unpredicted intracellular compartments in the absence of functional presenilin 1 expression. J. Biol. Chem. 275, 36794-36802 (2000).
100. Herreman, A. et al. Total inactivation of γ-secretase activity in presenilin-deficient embryonic stem cells. Nature Cell Biol. 2, 461-462 (2000).
101. Zhang, Z. et al. Presenilins are required for γ-secretase cleavage of β-APP and transmembrane cleavage of Notch-1. Nature Cell Biol. 2, 463-465 (2000).
102. Brou, C. et al. A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol. Cell 5, 207-216 (2000).
103. Mumm, J. S. et al. A ligand-induced extracellular cleavage regulates γ-secretase-like proteolytic activation of Notch1. Mol. Cell 5, 197-206 (2000).
104. Sisodia, S. S. β-Amyloid precursor protein cleavage by a membrane-bound protease. Proc. Natl Acad. Sci. USA 89, 6075-6079 (1993).
105. Schroeter, E. H., Kisslinger, J. A. & Kopan, R. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature 393, 382-386 (1998).
106. Weinmaster, G. Notch signal transduction: a real rip and more. Curr. Opin. Genet. Dev. 10, 363-369 (2000).
107. Chan, Y M. & Jan, Y N. Presenilins, processing of P-amyloid precursor protein, and Notch signaling. Neuron 23, 201-204 (1999).
108. Wong, P C. et al. Presenilin 1 is required for Notch and Dll1 expression in the paraxial mesoderm. Nature 387, 288-292 (1997).
109. Shen, J. et al. Skeletal and CNS defects in presenilin-1 deficient mice. Cell 89, 629-639 (1997).
110. Donoviel, D. et al. Mice lacking both presenilin genes exhibit early embryonic patterning defects. Genes Dev. 13, 2801-2810 (1999).
111. Herreman, A. et al. Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency. Proc. Natl Acad. Sci. USA 96, 11872-11877 (1999).
112. De Strooper, B. et al. A presenilin dependent γ-secretase- like protease mediates release of Notch intracellular domain. Nature 398, 518-522 (1999).
113. Ni, C. Y, Murphy, M. P, Golde, T E. & Carpenter, G. γ-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science 294, 2179-2181 (2001).
114. Fergani, A., Yu, G., St George-Hyslop, P. & Checler, F. Wild- type and mutated nicastrins do not display aminopeptidase M- and B-like activities. Biochem. Biophys. Res. Commun. 289, 678-680 (2001).
115. Wolfe, M. S. et al. Two transmembrane aspartates in presenilin 1 required for presenilin endoproteolysis and γ-secretase activity. Nature 398, 513-517 (1999).
116. Li, Y. M. et al. Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1. Nature 405, 689-694 (2000).
117. Esler, W. P et al. Transition-state analogue inhibitors of γ-secretase bind directly to presenilin-1. Nature Cell Biol. 2, 428-434 (2000).
118. Steiner, H. et al. Glycine 384 is required for presenilin-1 function and is conserved in bacterial polytopic aspartyl proteases. Nature Cell Biol. 2, 848-851 (2000).
119. Huppert, S. S. et al. Embryonic lethality in mice homozygous for a processing-deficient allele of Notch1. Nature 405, 966-970 (2000).
120. Lichtenthaler, S. F., Ida, N., Multhaup, G., Masters, C. L. & Beyreuther, K. Mutations in the transmembrane domain of APP altering γ-secretase specificity. Biochemistry 36, 15396-15403 (1997).
121. Yu, C. et al. Characterization of a presenilin-mediated amyloid precursor protein carboxyl-terminal fragment y Evidence for distinct mechanisms involved in γ-secretase processing of the APP and Notch1 transmembrane domains. J. Biol. Chem. 276, 43756-43760 (2001).
122. Gu, Y. et al. Distinct intramembrane cleavage of the β-amyloid precursor protein family resembling γ-secretase- like cleavage of Notch. J. Biol. Chem. 276, 35235-35238 (2001).
123. Kulic, L. et al. Separation of presenilin function in amyloid β-peptide generation and endoproteolysis of Notch. Proc. Natl Acad. Sci. USA 97, 5913-5918 (2000).
124. Petit, A. et al. New protease inhibitors prevent y-secretase- mediated Aβ40/42 production without affecting Notch cleavage. Nature Cell Biol. 3, 507-511 (2001).
125. Kim, S. H. et al. Multiple effects of aspartate mutant presenilin 1 on the processing and trafficking of amyloid precursor protein. J. Biol. Chem. 276, 43343-43350 (2001).
126. Capell, A. et al. Presenilin-1 differentially facilitates endoproteolysis of the β-amyloid precursor protein and Notch. Nature Cell Biol. 2, 205-211 (2000).
127. Murphy, M. P. et al. Presenilin 1 regulates pharmacologically distinct γ-secretase activities. Implications for the role of presenilin in γ-secretase cleavage. J. Biol. Chem. 275, 26277-26284 (2000).
128. Tomita, T. et al. The first proline of PALP motif at the C terminus of presenilins is obligatory for stabilization, complex formation, and γ-secretase activities of presenilins. J. Biol. Chem. 276, 33273-33281 (2001).
129. Yu, G. et al. Mutation of conserved aspartates affects maturation of both aspartate mutant and endogenous presenilin 1 and presenilin 2 complexes. J. Biol. Chem. 275, 27348-27353 (2000).
130. Perez, R. G. et al. Mutagenesis identifies new signals for β-amyloid precursor protein endocytosis, turnover, and the generation of secreted fragments, including Aβ42. J. Biol. Chem. 274, 18851-18856 (1999).
131. Arduengo, P M., Appleberry, O. K., Chuang, P & L'Hernault, S. W. The presenilin protein family member SPE-4 localizes to an ER/Golgi derived organelle and is required for proper cytoplasmic partitioning during Caenorhabditis elegans spermatogenesis. J. Cell Sci. 111, 3645-3654 (1998).
132. Annaert, W. G. et al. Interaction with telencephalin and the amyloid precursor protein predicts a ring structure for presenilins. Neuron 32, 579-589 (2001).
133. DeBose-Boyd, R. A. et al. Transport-dependent proteolysis of SREBP: relocation of site-1 protease from Golgi to ER obviates the need for SREBP transport to Golgi. Cell 99, 703-712 (1999).
134. Cai, H. et al. BACE1 is the major β-secretase for generation of Aβ peptides by neurons. Nature Neurosci. 4, 233-234 (2001).
135. Wong, P C., Price, D. L. & Cai, H. The brain's susceptibility to amyloid plaques. Science 293, 1434 (2001).
136. Hadland, B. K. et al. γ-Secretase inhibitors repress thymocyte development. Proc. Natl Acad. Sci. USA 98, 7487-7491 (2001).
137. St George-Hyslop, P. H. Piecing together Alzheimer's. Sci. Am. 283, 76-83 (2000)